Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection Pubmed



Hosseini P1 ; Rahimi H2 ; Najafabadi MM3 ; Ghorbani A4, 10 ; Najafabadi SK5 ; Faridzadeh A6, 11 ; Arabpour J7 ; Khormali E8 ; Deravi N9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran
  3. 3. Department of medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Biology, Faculty of Basic Sciences, East Tehran Branch (Ghiamdasht), Islamic Azad University, Tehran, Iran
  5. 5. Department of medicine, Isfahan University of Medical Sciences (IUMS), Isfahan, Iran
  6. 6. Department of Immunology and Allergy, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  7. 7. Student Research Committee, Department of Microbiology, Faculty of New Sciences, Tehran Medical Branch, Islamic Azad University, Tehran, Iran
  8. 8. Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  9. 9. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  10. 10. Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  11. 11. Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Acta Medica Indonesiana Published:2021


Abstract

The global widespread mortality after the emergence of SARS-CoV-2 infection in China, has become a critical concern all around the world. Convalescent plasma (CP) therapy is one of the methods elevating the survival rate for COVID-19 infection cases. This technique, as a practicable therapy, was used in previous viral outbreaks including influenza, SARS and MERS. In CP therapy, the blood plasma is collected from persons rehabilitated from that specific infection in order to develop a passive immunity in other patients. Therefore, this review aimed to point out the role of CP therapy in aforementioned viral infections and illustrate different factors influencing the efficacy of CP therapy. © 2021, Indonesian Society of Internal Medicine. All rights reserved.
Related Docs
View other Related Docs
1. Convalescent Plasma Against Covid-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases, Microorganisms (2020)
2. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
3. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
4. Immunological Effects of Convalescent Plasma Therapy for Coronavirus: A Scoping Review, BMC Infectious Diseases (2021)
5. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
6. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
7. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
8. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (6)
Saeed Mohammadi (3)
Other Related Docs
9. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
10. The Effectiveness of Convalescent Plasma Administered on the First Day of Admission for Covid-19 Patients: An Open-Label Randomized Controlled Trial, Infectious Diseases and Immunity (2025)
11. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
12. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
13. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
14. Ubiquitous Convalescent Plasma: An Artificial Universal Plasma for Covid-19 Patients, Transfusion and Apheresis Science (2021)
15. Convalescent Plasma Therapy in Patients With Severe Covid-19, a Single-Arm, Retrospective Study, Microbial Pathogenesis (2022)
16. The Demographic and Serological Characteristics of Covid-19 Convalescent Plasma Donors: Identification of Basic Criteria for Optimal Donor Selection, Transfusion and Apheresis Science (2022)
17. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
18. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
19. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
20. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
21. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
22. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
23. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
24. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
25. Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19, Allergy# Asthma and Clinical Immunology (2021)
26. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
27. Early High-Titer Convalescent Plasma Therapy in Patients With Moderate and Severe Covid-19, Transfusion and Apheresis Science (2022)
28. A Review on Coronavirus Disease 2019 (Covid-19) in Pediatric Patients, Archives of Pediatric Infectious Diseases (2020)